 |
Principal
Investigator: Paul
Latkany, MD
Enrollment
Status:
Open
Objective:
The purpose of this study is to examine the efficacy and safety data in patients with intermediate, pan-, or posterior uveitis, comparing systemic therapy vs. Fluocinolone Acetonide (FA) Implant. Primary end point is Visual Acuity.
Eligibility:
Contact Principal
Investigator
Contact
Information:
- Principal
Investigator: Paul Latkany, MD at (212) 687-0265
|